A detailed history of Darden Wealth Group Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Darden Wealth Group Inc holds 3,031 shares of JNJ stock, worth $439,646. This represents 0.35% of its overall portfolio holdings.

Number of Shares
3,031
Previous 3,076 1.46%
Holding current value
$439,646
Previous $450 Million 9.26%
% of portfolio
0.35%
Previous 0.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $6,546 - $7,532
-45 Reduced 1.46%
3,031 $491 Million
Q2 2024

Aug 06, 2024

SELL
$144.38 - $157.78 $126,765 - $138,530
-878 Reduced 22.21%
3,076 $450 Million
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $110,050 - $115,382
-709 Reduced 15.2%
3,954 $626 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $678,932 - $740,857
4,663 New
4,663 $731 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Darden Wealth Group Inc Portfolio

Follow Darden Wealth Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darden Wealth Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Darden Wealth Group Inc with notifications on news.